V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20218773 | 20156326 | 0 | 65.85 | null | null | null | LANREOTIDE | null | null | LANREOTIDE | 100722399 |
| 20218793 | 20156329 | 0 | 71 | null | 2019-05-11 | 2019-06-01 | null | 02 | null | FLUOROURACIL + MITOMYCIN | 101440901 |
| 20218801 | 20156330 | 1.73 | 63.6 | null | 2016-11-14 | 2018-07-06 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101749725 |
| 20218807 | 20156331 | 1.67 | 55.1 | Curative (C) | 2016-07-02 | 2016-07-25 | null | 02 | Y | DOXORUBICIN EMBOLISATION | 100772723 |
| 20218808 | 20156332 | 1.81 | 52 | null | null | 2019-12-05 | null | 02 | null | LANREOTIDE | 100172881 |
| 20218816 | 20156333 | 0 | 93.8 | Palliative (P) | null | 2016-03-27 | null | 02 | N | HCX | 101098703 |
| 20218840 | 20156335 | null | null | 03 | null | 2019-08-07 | null | 99 | N | HCX | 100668283 |
| 20218845 | 20156336 | 0 | null | null | 2019-05-12 | 2020-03-17 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101000297 |
| 20218860 | 20156337 | 0 | 77 | Palliative (P) | 2019-04-28 | 2019-12-30 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100295138 |
| 20218868 | 20156338 | 0 | 112 | null | 2020-01-08 | 2020-01-30 | Cape+Cisplatin+Trastuzumab Main | 02 | null | LANREOTIDE | 101861290 |
| 20218881 | 20156339 | 1.6 | null | Palliative (P) | 2020-06-26 | 2020-07-13 | Cape+Cisplatin+Trastuzumab Main | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101696898 |
| 20218895 | 20156340 | 0 | 0 | Palliative (P) | 2019-11-05 | 2019-11-13 | null | 2 | N | HCX | 101236663 |
| 20218898 | 20156341 | 0 | 49 | null | 2017-02-18 | 2017-03-25 | null | 02 | N | FLUOROURACIL + MITOMYCIN | 101049482 |
| 20218904 | 20156342 | 0 | 63.4 | 03 | null | 2016-07-26 | LANREOTIDE | null | N | LANREOTIDE | 100876009 |
| 20218913 | 20156344 | 0 | null | Curative (C) | 2019-05-19 | 2019-07-01 | FLUOROURACIL + MITOMYCIN | 02 | N | FLUOROURACIL + MITOMYCIN | 100259866 |
| 20218920 | 20156345 | 0 | 59.3 | Curative (C) | 2016-05-26 | 2016-06-08 | FLUOROURACIL + MITOMYCIN | 02 | Y | FLUOROURACIL + MITOMYCIN | 100150757 |
| 20218926 | 20156346 | 0 | null | null | 2017-02-08 | 2017-02-25 | null | 02 | null | FLUOROURACIL + MITOMYCIN | 100726946 |
| 20218932 | 20156347 | 0 | 73.1 | Curative (C) | 2018-05-09 | 2019-01-19 | OXALIPLATIN + MDG + PANITUMUMAB | null | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101363860 |
| 20218943 | 20156350 | 0 | null | null | null | 2018-05-12 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101319096 |
| 20218956 | 20156352 | 0 | 54 | null | 2019-03-23 | 2019-05-04 | HCX (Cape + Cisp + Tras) - Main | 02 | null | DOXORUBICIN EMBOLISATION | 100280171 |
| 20218957 | 20156353 | 0 | 104 | null | 2016-02-13 | 2016-08-07 | null | null | null | LENVATINIB | 100773472 |
| 20218980 | 20156356 | 0 | 99.7 | null | null | 2019-06-20 | HCX | 02 | null | CAPECITABINE + MITOMYCIN | 100898090 |
| 20219001 | 20156357 | 0 | null | null | 2018-11-17 | 2018-12-09 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100802652 |
| 20219015 | 20156359 | 1.84 | null | null | 2018-07-25 | 2018-08-13 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100687325 |
| 20219036 | 20156361 | 0 | 0 | Palliative (P) | 2016-10-07 | 2018-02-10 | null | 02 | N | CAPECITABINE + MITOMYCIN | 100669537 |
| 20219039 | 20156362 | 0 | 72.6 | null | 2019-08-14 | 2019-09-25 | LENVATINIB | null | null | LENVATINIB | 100413873 |
| 20219040 | 20156363 | 0 | 61.8 | Palliative (P) | 2017-09-26 | 2017-09-26 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 101387553 |
| 20219070 | 20156365 | 0 | null | null | 2017-06-28 | 2017-06-29 | LENVATINIB | 02 | null | LENVATINIB | 101182565 |
| 20219083 | 20156367 | 0 | 87.2 | Curative (C) | 2016-03-31 | 2016-08-25 | null | 02 | Y | HCX | 100443132 |
| 20219090 | 20156369 | 0 | null | null | 2017-06-18 | 2019-02-24 | null | 2 | null | HCX | 100149596 |
| 20219108 | 20156372 | 0 | null | Neo-adjuvant (N) | 2016-07-24 | 2016-07-24 | LENVATINIB | 02 | N | LENVATINIB | 100876273 |
| 20219116 | 20156373 | 0 | 91.4 | Neo-adjuvant (N) | 2019-01-12 | 2019-01-21 | LANREOTIDE | 02 | N | LANREOTIDE | 101195697 |
| 20219138 | 20156374 | 0 | 0 | Curative (C) | 2017-04-27 | 2017-05-11 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101839366 |
| 20219142 | 20156375 | 0 | null | Curative (C) | 2018-10-08 | 2018-10-26 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN | 100437881 |
| 20219163 | 20156377 | 0 | 40 | null | 2019-02-11 | 2019-11-12 | null | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101715870 |
| 20219166 | 20156378 | 1.75 | null | null | 2019-07-26 | 2019-10-02 | null | 02 | null | LANREOTIDE | 101018147 |
| 20219184 | 20156379 | 0 | 0 | null | 2019-07-04 | 2020-02-06 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100180009 |
| 20219216 | 20156383 | 0 | 70 | null | 2017-03-30 | 2018-04-16 | LANREOTIDE | N | Y | LANREOTIDE | 101734591 |
| 20219221 | 20156384 | 0 | 135 | Curative (C) | 2016-07-01 | 2016-07-31 | FLUOROURACIL + MITOMYCIN | 02 | N | FLUOROURACIL + MITOMYCIN | 100628264 |
| 20219230 | 20156385 | 0 | null | null | 2017-07-29 | 2017-11-22 | null | 02 | null | CAPECITABINE + MITOMYCIN | 101308545 |
| 20219249 | 20156386 | 0 | 105.25 | null | null | 2020-05-15 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100428763 |
| 20219262 | 20156387 | null | null | Palliative (P) | 2017-05-28 | 2017-06-24 | null | 02 | N | LANREOTIDE | 100529146 |
| 20219270 | 20156389 | 0 | null | null | 2019-06-15 | 2019-07-22 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 101214843 |
| 20219282 | 20156391 | 0 | 103 | Palliative (P) | 2018-11-27 | 2018-12-06 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101819045 |
| 20219303 | 20156394 | 0 | 84.7 | Palliative (P) | 2019-01-27 | 2019-02-17 | null | 02 | N | HCX | 101309556 |
| 20219317 | 20156395 | 0 | null | null | 2016-11-24 | 2016-11-28 | LANREOTIDE | 02 | null | LANREOTIDE | 101420927 |
| 20219321 | 20156396 | 0 | null | null | 2020-04-25 | 2020-09-05 | OXALIPLATIN + MDG + PANITUMUMAB | 99 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101580980 |
| 20219322 | 20156397 | 0 | 61.4 | null | 2017-04-27 | 2018-06-24 | FLUOROURACIL + MITOMYCIN | 02 | null | FLUOROURACIL + MITOMYCIN | 101850825 |
| 20219335 | 20156398 | 0 | 90.25 | Palliative (P) | null | 2017-08-03 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 100812155 |
| 20219351 | 20156400 | 0 | 97.5 | Palliative (P) | 2018-07-11 | 2018-08-01 | Cape+Cisplatin+Trastuzumab Main | 02 | null | HCX | 101564360 |